1
|
Li JJ: Inflammation: an important
mechanism for different clinical entities of coronary artery
diseases. Chin Med J (Engl). 118:1817–1826. 2005.PubMed/NCBI
|
2
|
Hu D: Cardiology in new millennium: what
will the 21st century bring. Chin Med J (Engl). 113:3–4.
2000.PubMed/NCBI
|
3
|
Yeh HI, Lai YJ, Chang HM, Ko YS, Severs NJ
and Tsai CH: Multiple connexin expression in regenerating arterial
endothelial gap junctions. Arterioscler Thromb Vasc Biol.
20:1753–1762. 2000. View Article : Google Scholar : PubMed/NCBI
|
4
|
Derouette JP, Wong C, Burnier L, et al:
Molecular role of Cx37 in advanced atherosclerosis: a micro-array
study. Atherosclerosis. 206:69–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Van Camp G, Coucke P, Speleman F, Van Roy
N, Beyer EC, Oostra BA and Willems PJ: The gene for human gap
junction protein connexin37 (GJA4) maps to chromosome 1p35.1, in
the vicinity of D1S195. Genomics. 30:402–403. 1995.PubMed/NCBI
|
6
|
Cooper CD, Solan JL, Dolejsi MK and Lampe
PD: Analysis of connexin phosphorylation sites. Methods.
20:196–204. 2000. View Article : Google Scholar : PubMed/NCBI
|
7
|
Listì F, Candore G, Lio D, et al:
Association between C1019T polymorphism of connexin37 and acute
myocardial infarction: a study in patients from Sicily. Int J
Cardiol. 102:269–271. 2005.PubMed/NCBI
|
8
|
Wong CW, Christen T, Pfenniger A, James RW
and Kwak BR: Do allelic variants of the connexin37 1019 gene
polymorphism differentially predict for coronary artery disease and
myocardial infarction? Atherosclerosis. 191:355–361. 2007.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang SR, Xu LX, Zhang HQ, Gao QQ, Lin J
and Huang WJ: The association between Connexin 37 gene C1019T
polymorphism and coronary heart disease. Prev and Treat of
Cardio-Cereb-Vasc Dis. 7:390–392. 2007.
|
10
|
Han Y, Xi S, Zhang X, Yan C, Yang Y and
Kang J: Association of Connexin 37 gene polymorphisms with risk of
coronary artery disease in northern Han Chinese. Cardiology.
110:260–265. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhang CL, Wang Q, Zheng L, et al:
Association study between C1019T polymorphism in the connexin37
gene and acute myocardial infarction in patients from Cantonese
population of China. J Guangxi Med Univ. 25:844–847. 2008.
|
12
|
Cochran WG: The effectiveness of
adjustment by subclassification in removing bias in observational
studies. Biometrics. 24:295–313. 1968. View
Article : Google Scholar : PubMed/NCBI
|
13
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
15
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yeh HI, Chou Y, Liu HF, Chang SC and Tsai
CH: Connexin37 gene polymorphism and coronary artery disease in
Taiwan. Int J Cardiol. 81:251–255. 2001. View Article : Google Scholar : PubMed/NCBI
|
17
|
Xie XJ, Guo WY, Li LS, Shu Q, Jiang WR,
Zhang SZ and Li F: Association between Connexin 37 gene
polymorphism and coronary heart disease. Chin Heart J. 18:539–541.
2006.
|
18
|
Feng W, Wang HJ and Wang Y: Relevance of
Connexin 37 gene C1019T polymorphism and coronary heart disease in
Han population in Anhui region. Chin J Cardiovasc Rehabil Med.
19:33–36. 2010.
|
19
|
Shimokawa H: Primary endothelial
dysfunction: atherosclerosis. J Mol Cell Cardiol. 31:23–37. 1999.
View Article : Google Scholar
|
20
|
Severs NJ, Rothery S, Dupont E, et al:
Immunocytochemical analysis of connexin expression in the healthy
and diseased cardiovascular system. Microsc Res Tech. 52:301–322.
2001. View Article : Google Scholar
|
21
|
Wong CW, Christen T, Roth I, et al:
Connexin37 protects against atherosclerosis by regulating monocyte
adhesion. Nat Med. 12:950–954. 2006. View
Article : Google Scholar : PubMed/NCBI
|
22
|
Galkina E and Ley K: Vascular adhesion
molecules in atherosclerosis. Arterioscler Thromb Vasc Biol.
27:2292–2301. 2007. View Article : Google Scholar
|
23
|
Yeh HI, Rothery S, Dupont E, Coppen SR and
Severs NJ: Individual gap junction plaques contain multiple
connexins in arterial endothelium. Circ Res. 83:1248–1263. 1998.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Collings A, Islam MS, Juonala M, et al:
Associations between connexin37 gene polymorphism and markers of
subclinical atherosclerosis: the Cardiovascular Risk in Young Finns
study. Atherosclerosis. 195:379–384. 2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Lanfear DE, Jones PG, Marsh S, Cresci S,
Spertus JA and McLeod HL: Connexin37 (GJA4) genotype predicts
survival after an acute coronary syndrome. Am Heart J. 154:561–566.
2007. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wang F, Yang C, Song Y, Jiang Y and Ding
Z: Periostin gene polymorphisms, protein levels and risk of
incident coronary artery disease. Mol Biol Rep. 39:359–367. 2012.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Saedi M, Vaisi-Raygani A, Khaghani S, et
al: Matrix metalloproteinas-9 functional promoter polymorphism
1562C>T increased risk of early-onset coronary artery disease.
Mol Biol Rep. 39:555–562. 2012.
|
28
|
Al-Daghri NM, Al-Attas OS, Alokail MS,
Alkharfy KM and Hussain T: Adiponectin gene variants and the risk
of coronary artery disease in patients with type 2 diabetes. Mol
Biol Rep. 38:3703–3708. 2011. View Article : Google Scholar : PubMed/NCBI
|